{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:26:39Z","timestamp":1778851599310,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejphar.2017.07.038","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T14:01:16Z","timestamp":1500645676000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inhibition of lipolysis by ilexgenin A via AMPK activation contributes to the prevention of hepatic insulin resistance"],"prefix":"10.1016","volume":"813","author":[{"given":"Lan-Zhu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.07.038_bib1","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-15-0447","article-title":"Current understanding of metformin effect on the control of hyperglycemia in diabetes","volume":"228","author":"An","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tem.2014.03.002","article-title":"Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance","volume":"25","author":"Arner","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2017.07.038_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/CS20120536","article-title":"Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation","volume":"124","author":"Bijland","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2017.07.038_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.intimp.2016.08.024","article-title":"A novel pentacyclic triterpenoid, Ilexgenin A, shows reduction of atherosclerosis in apolipoprotein E deficient mice","volume":"40","author":"Chang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ddr.21066","article-title":"Ilexgenin A obtained from ilex hainanensis Merr. improves diet-induced non-alcoholic fatty liver disease in rats","volume":"74","author":"Cui","year":"2013","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2017.07.038_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1142\/S0192415X13500353","article-title":"Triterpenoid-rich fraction from ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats","volume":"41","author":"Cui","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejphar.2017.07.038_bib7","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db14-1098","article-title":"Monounsaturated fatty acid enriched high fat-diets impede adipose NLRP3 inflammasome mediated IL-1\u03b2 secretion and insulin resistance despite obesity","volume":"64","author":"Finucane","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2017.07.038_bib8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2337\/db13-0194","article-title":"Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice","volume":"63","author":"Geerling","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2017.07.038_bib9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2017.07.038_bib10","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/MCB.00244-16","article-title":"AMPK phosphorylates desnutrin\/ATGL and HSL to regulate lipolysis and fatty acid oxidation within adipose tissue","volume":"36","author":"Kim","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib11","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2017.07.038_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.plipres.2009.05.001","article-title":"Lipolysis and lipid mobilization in human adipose tissue","volume":"48","author":"Lafontan","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2017.07.038_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2007.11.006","article-title":"Control of lipolysis by natriuretic peptides and cyclic GMP","volume":"19","author":"Lafontan","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2017.07.038_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","article-title":"Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes","volume":"68","author":"Levelt","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2015.05.012","article-title":"Ilexgenin A inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP\/NLRP3 inflammasome activation in an AMPK dependent manner","volume":"99","author":"Li","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2017.07.038_bib16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","article-title":"Links between ectopic fat and vascular disease in humans","volume":"34","author":"Lim","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib17","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.2337\/db15-1122","article-title":"AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity","volume":"65","author":"Luo","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2017.07.038_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.07.038_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/JME-13-0277","article-title":"Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease","volume":"52","author":"Nielsen","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2017.07.038_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.07.038_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2017.07.038_bib22","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2017.07.038_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2017.07.038_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2017.07.038_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nm.2756","article-title":"NF-\u03baB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action","volume":"18","author":"Sheng","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2017.07.038_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejphar.2017.07.038_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2017.07.038_bib28","doi-asserted-by":"crossref","first-page":"E832","DOI":"10.1152\/ajpendo.00328.2010","article-title":"IL-6 selectively stimulates fat metabolism in human skeletal muscle","volume":"299","author":"Wolsk","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2017.07.038_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/db15-0941","article-title":"Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance","volume":"65","author":"Wueest","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2017.07.038_bib30","doi-asserted-by":"crossref","first-page":"40477","DOI":"10.1074\/jbc.M111.257923","article-title":"Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-\u03b1 (TNF-\u03b1)-induced lipolysis in adipocytes","volume":"286","author":"Yang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.07.038_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","article-title":"Fat signals \u2013 lipases and lipolysis in lipid metabolism and signaling","volume":"15","author":"Zechner","year":"2012","journal-title":"Cell Metab."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917304946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T04:50:32Z","timestamp":1659243032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917304946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":31,"alternative-id":["S0014299917304946"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of lipolysis by ilexgenin A via AMPK activation contributes to the prevention of hepatic insulin resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}